| abstract |
The present invention provides a novel polynucleotide, polypeptide, recombinant vector, transformant, and pharmaceutical which can easily utilize a serine protease activity having high substrate specificity. A polynucleotide having a specific nucleotide sequence and a polypeptide encoded thereby. An expression vector incorporating the polynucleotide. A transformed cell lightly transformed by introducing the recombinant vector. Pharmaceutical products containing the polynucleotide or polypeptide as an active ingredient and mainly used as antithrombotic agents. [Selection diagram] None |